The observations led the investigators to correlate the TMB expression extents with immune cell infiltration and inflammation-mediated T-cell mediated response, together enhancing the sensitivity to PD-1/PD-L1 blockade in the NSCLC cells expressing PD-L1 [252]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.